Early Weight Loss While on Lorcaserin, Diet and Exercise as a Predictor of Week 52 Weight-Loss Outcomes

摘要

ObjectiveTo identify an early treatment milestone that optimizes sensitivity and specificity for predicting 5% weight loss at Week (W) 52 in patients with and without type 2 diabetes on lorcaserin or placebo.